Evaluation of a novel CD20-targeted IL-15 immunotherapeutic with potent activity against B cell lymphoma
Year: 2014
Type: conference-abstract
Abstract: Meeting abstracts IL-15 exhibits potent antitumor efficacy in mouse models through its ability to promote proliferation and activation of NK cells and memory CD8+ T cells. Recently, targeting approaches have been developed to direct these activities against tumor cells and minimize potential
Institution: Altor BioScience (United States)
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2018491566